Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology
ACS Applied Bio Materials · 17.11.2025 · 8 (11) · 9542-9556
DOI: 10.1021/acsabm.5c00982 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, online erschienen am 07.11.2025. Verfasst von Oksana Sulaieva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory CSD, Kyiv 03022, Ukraine. Hauptthemen laut MEDLINE: Tumor Microenvironment, Antineoplastic Agents, Neoplasms, Biocompatible Materials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, MSCA4Ukraine project I-NanoTerm, LRC Project.
Abstract (Originalsprache)
The emergence of two-dimensional (2D) nanomaterials such as MXenes has significantly expanded opportunities in precision oncology. With their high surface area, tunable surface chemistry, strong photothermal conversion efficiency, and intrinsic biocompatibility, MXenes offer promising potential for cancer nanotheranostics. This review explores the therapeutic applications of MXenes, focusing on their dual roles in direct tumor ablation and modulation of the tumor immune microenvironment (TIME). MXenes exert anticancer effects through reactive oxygen species-mediated cytotoxicity and localized photothermal heating while also influencing immune cell function and tumor-immune interactions. Recent studies using single-cell sequencing and high-dimensional immune profiling highlight the capacity of MXenes to modulate immune-mediated tumor cell death. Their selective reactivity in the acidic tumor milieu, linked to the Warburg effect, makes them ideal candidates for pH-responsive drug delivery. We further discuss synergistic strategies combining MXene-based photothermal therapy with chemotherapy, targeted agents, and immunotherapies. Advancing MXene-based cancer therapies requires an integrated understanding of tumor biology, metabolic reprogramming, and TIME dynamics. This multidisciplinary approach is essential for the development of safe, selective, and personalized nanomedicine platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Laboratory CSD, Kyiv 03022, Ukraine.
- Kyiv Medical University, Kyiv 02099, Ukraine.
- Ukrainian Association of Precision Medicine, Kyiv 03117, Ukraine.
- Bogomolets National Medical University, Kyiv 01601, Ukraine.
- Sumy State University, Sumy 40014, Ukraine.
- University of Latvia, Riga LV-1586, Latvia.
ORCID-Profile: Oksana Sulaieva, Maksym Pogorielov, Volodymyr Deineka
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- MSCA4Ukraine project I-NanoTerm
- LRC Project
Zitieren
APA
Sulaieva, O., Kobyliak, N., Panko, I., Meged, T., Gaidamak, O., Pogorielov, M., & Deineka, V. (2025). Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology. ACS Applied Bio Materials, 8(11), 9542-9556. https://doi.org/10.1021/acsabm.5c00982
Vancouver
Sulaieva O, Kobyliak N, Panko I, Meged T, Gaidamak O, Pogorielov M, et al. Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology. ACS Applied Bio Materials. 2025;8(11):9542-9556. doi:10.1021/acsabm.5c00982
BibTeX
@article{Sulaieva2025,
author = {Sulaieva, Oksana and Kobyliak, Nazarii and Panko, Ihor and Meged, Tetiana and Gaidamak, Olena and Pogorielov, Maksym and Deineka, Volodymyr},
title = {Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology},
journal = {ACS Applied Bio Materials},
year = {2025},
volume = {8},
number = {11},
pages = {9542--9556},
doi = {10.1021/acsabm.5c00982}
}
EUVIMED